BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 33270893)

  • 1. Interaction of OIP5-AS1 with MEF2C mRNA promotes myogenic gene expression.
    Yang JH; Chang MW; Pandey PR; Tsitsipatis D; Yang X; Martindale JL; Munk R; De S; Abdelmohsen K; Gorospe M
    Nucleic Acids Res; 2020 Dec; 48(22):12943-12956. PubMed ID: 33270893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA OIP5-AS1-directed miR-7 degradation promotes MYMX production during human myogenesis.
    Yang JH; Chang MW; Tsitsipatis D; Yang X; Martindale JL; Munk R; Cheng A; Izydore E; Pandey PR; Piao Y; Mazan-Mamczarz K; De S; Abdelmohsen K; Gorospe M
    Nucleic Acids Res; 2022 Jul; 50(12):7115-7133. PubMed ID: 35736212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR.
    Kim J; Abdelmohsen K; Yang X; De S; Grammatikakis I; Noh JH; Gorospe M
    Nucleic Acids Res; 2016 Mar; 44(5):2378-92. PubMed ID: 26819413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stoichiometry of long noncoding RNA interactions with other RNAs: Insights from OIP5-AS1.
    Yang JH; Tsitsipatis D; Gorospe M
    Wiley Interdiscip Rev RNA; 2024; 15(2):e1841. PubMed ID: 38576135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-binding protein AUF1 promotes myogenesis by regulating MEF2C expression levels.
    Panda AC; Abdelmohsen K; Yoon JH; Martindale JL; Yang X; Curtis J; Mercken EM; Chenette DM; Zhang Y; Schneider RJ; Becker KG; de Cabo R; Gorospe M
    Mol Cell Biol; 2014 Aug; 34(16):3106-19. PubMed ID: 24891619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA OIP5-AS1/cyrano suppresses GAK expression to control mitosis.
    Kim J; Noh JH; Lee SK; Munk R; Sharov A; Lehrmann E; Zhang Y; Wang W; Abdelmohsen K; Gorospe M
    Oncotarget; 2017 Jul; 8(30):49409-49420. PubMed ID: 28472763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
    Zhang M; Zhu B; Davie J
    J Biol Chem; 2015 Jan; 290(1):310-24. PubMed ID: 25404735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA OIP5-AS1 Promotes Cell Apoptosis and Cataract Formation by Blocking POLG Expression Under Oxidative Stress.
    Jing R; Ma B; Qi T; Hu C; Liao C; Wen C; Shao Y; Pei C
    Invest Ophthalmol Vis Sci; 2020 Oct; 61(12):3. PubMed ID: 33006594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA Irm enhances myogenic differentiation by interacting with MEF2D.
    Sui Y; Han Y; Zhao X; Li D; Li G
    Cell Death Dis; 2019 Feb; 10(3):181. PubMed ID: 30792383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer.
    Yang J; Jiang B; Hai J; Duan S; Dong X; Chen C
    J Cell Biochem; 2019 Jan; 120(1):907-916. PubMed ID: 30188591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lnc-ORA interacts with microRNA-532-3p and IGF2BP2 to inhibit skeletal muscle myogenesis.
    Cai R; Zhang Q; Wang Y; Yong W; Zhao R; Pang W
    J Biol Chem; 2021; 296():100376. PubMed ID: 33548229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA-MEG3 promotes bovine myoblast differentiation by sponging miR-135.
    Liu M; Li B; Peng W; Ma Y; Huang Y; Lan X; Lei C; Qi X; Liu GE; Chen H
    J Cell Physiol; 2019 Aug; 234(10):18361-18370. PubMed ID: 30887511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA OIP5-AS1 promotes the stemness of lung cancer cells through enhancing Oct4 mRNA stability.
    Mao C; Li X
    Environ Toxicol; 2022 May; 37(5):1104-1112. PubMed ID: 35044041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
    Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
    Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA
    Wang S; Tan B; Xiao L; Zeng J; Zhao X; Hong L; Li Z; Cai G; Zheng E; Gu T; Wu Z
    Epigenetics; 2022 Dec; 17(13):2039-2055. PubMed ID: 35899799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA complementarity and target transcripts abundance.
    Zealy RW; Fomin M; Davila S; Makowsky D; Thigpen H; McDowell CH; Cummings JC; Lee ES; Kwon SH; Min KW; Yoon JH
    Biochim Biophys Acta Gene Regul Mech; 2018 Mar; 1861(3):224-234. PubMed ID: 29421307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
    Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
    Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy.
    Baruffaldi F; Montarras D; Basile V; De Feo L; Badodi S; Ganassi M; Battini R; Nicoletti C; Imbriano C; Musarò A; Molinari S
    Stem Cells; 2017 Mar; 35(3):725-738. PubMed ID: 27612437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA OPA-interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR-143-3p.
    Chen X; Xiong D; Yang H; Ye L; Mei S; Wu J; Chen S; Shang X; Wang K; Huang L
    J Cell Physiol; 2019 Apr; 234(4):5264-5275. PubMed ID: 30341904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-204-5p regulates C2C12 myoblast differentiation by targeting MEF2C and ERRγ.
    Cheng X; Du J; Shen L; Tan Z; Jiang D; Jiang A; Li Q; Tang G; Jiang Y; Wang J; Li X; Zhang S; Zhu L
    Biomed Pharmacother; 2018 May; 101():528-535. PubMed ID: 29505923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.